TY - JOUR
T1 - Monitoring vascular changes in renal fibrosis in mice using multimodal optical and ultrasonic imaging
AU - Zhang, Ruijing
AU - Zhang, Yuhang
AU - Lu, Chuanlong
AU - Fan, Keyi
AU - Wang, Heng
AU - Wang, Qian
AU - Ning, Yijie
AU - Li, Yaling
AU - Zhang, Zeyu
AU - Jia, Xiaohua
AU - Dong, Honglin
N1 - Publisher Copyright:
© 2026 The Author(s). Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers.
PY - 2026
Y1 - 2026
N2 - Chronic kidney disease (CKD) has become one of the major diseases threatening global health, with its increasing incidence and mortality rates. Early identification of chronic kidney disease is crucial for accurate disease staging, timely intervention, and improved prognosis. However, the commonly used clinical diagnostic indicators, such as creatinine, albumin level and glomerular filtration rate, can only identify advanced CKD. Imaging examinations, such as computed tomography and magnetic resonance imaging, have limitations such as high costs and high risk of complications, and are not suitable for large-scale screening of high-risk populations. Renal biopsy is the gold standard for diagnosing renal fibrosis, but it is invasive. Previous studies have shown that capillary rarefaction is an early event of renal fibrosis, occurring earlier than tubular atrophy and interstitial collagen deposition. However, there is a lack of a minimally invasive, low-cost, high-resolution, dynamic and real-time monitoring method for renal microcirculation that is suitable for large-scale screening. There is an urgent need for reliable methods to screen early-stage CKD patients. In this study, we have for the first time combined real-time and wide-field laser speckle imaging (RFLSI), near-infrared II imaging (NIR-II), duplex ultrasound (DUS) and Contrast-Enhanced Ultrasound (CEUS) to monitor vascular changes and evaluate the progression of renal fibrosis. The combination of four imaging methods enabled the early monitoring of CKD progression by monitoring microcirculation. Among them, CEUS can detect changes in the renal microcirculation at the early stage of renal fibrosis, even earlier than the pathological damage of the kidneys. Through visualization and quantification of the progression of renal fibrosis and validation through histopathology, this study utilizes preclinical imaging to supplement clinical imaging of renal fibrosis, providing a more comprehensive method for monitoring microcirculation, which is helpful for guiding clinical decisions and providing insights into disease progression.
AB - Chronic kidney disease (CKD) has become one of the major diseases threatening global health, with its increasing incidence and mortality rates. Early identification of chronic kidney disease is crucial for accurate disease staging, timely intervention, and improved prognosis. However, the commonly used clinical diagnostic indicators, such as creatinine, albumin level and glomerular filtration rate, can only identify advanced CKD. Imaging examinations, such as computed tomography and magnetic resonance imaging, have limitations such as high costs and high risk of complications, and are not suitable for large-scale screening of high-risk populations. Renal biopsy is the gold standard for diagnosing renal fibrosis, but it is invasive. Previous studies have shown that capillary rarefaction is an early event of renal fibrosis, occurring earlier than tubular atrophy and interstitial collagen deposition. However, there is a lack of a minimally invasive, low-cost, high-resolution, dynamic and real-time monitoring method for renal microcirculation that is suitable for large-scale screening. There is an urgent need for reliable methods to screen early-stage CKD patients. In this study, we have for the first time combined real-time and wide-field laser speckle imaging (RFLSI), near-infrared II imaging (NIR-II), duplex ultrasound (DUS) and Contrast-Enhanced Ultrasound (CEUS) to monitor vascular changes and evaluate the progression of renal fibrosis. The combination of four imaging methods enabled the early monitoring of CKD progression by monitoring microcirculation. Among them, CEUS can detect changes in the renal microcirculation at the early stage of renal fibrosis, even earlier than the pathological damage of the kidneys. Through visualization and quantification of the progression of renal fibrosis and validation through histopathology, this study utilizes preclinical imaging to supplement clinical imaging of renal fibrosis, providing a more comprehensive method for monitoring microcirculation, which is helpful for guiding clinical decisions and providing insights into disease progression.
KW - chronic kidney disease
KW - continuous microcirculation monitoring
KW - contrast-enhanced ultrasound
KW - diabetic kidney disease
KW - duplex ultrasound
KW - near-infrared II imaging
KW - real-time and wide-field laser speckle imaging
UR - https://www.scopus.com/pages/publications/105046918919
U2 - 10.1002/btm2.70169
DO - 10.1002/btm2.70169
M3 - 文章
AN - SCOPUS:105046918919
SN - 2380-6761
JO - Bioengineering and Translational Medicine
JF - Bioengineering and Translational Medicine
ER -